Belharra Therapeutics
Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.
| Company Details | |
|---|---|
| Title | Belharra Therapeutics |
| Industries | Biotechnology, Chemical, Therapeutics |
| Headquarters Regions | Greater San Diego Area, West Coast, Western US |
| Headquarters Location | San Diego, California, United States |
| No Of Employees | 11-50 |
| Operating Status | Active |
Description
Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational state, and in any cell type using its chemoproteomics platform. Belharra is based in the San Francisco Bay Area, with its primary lab and offices in San Diego.